Medical Supplies Reimagined
The medical supply chain is broken, and healthcare providers and patients are suffering as a result. iRemedy is working to solve that problem by creating one of the world’s largest and most powerful procurement marketplace — powered by our patented AI technology.
THIS IS THE FUTURE OF HEALTHCARE
The Medical Supply Industry
The medical supplies market is projected to reach $163.5 billion by 2027 from $138.4 billion in 2022, at a CAGR of 3.4% during the forecast period. The growth in this market is driven by the increasing demand for infection control measures to control hospital-acquired infections, increasing demand for medical devices, increasing number of ICU beds in hospitals and surgical centers, and rising number of accidents and trauma cases.
What Makes iRemedy Different From Others?
The typical medical supplier in the United States is over 100 years old. They were born before most homes had electricity and TVs, and before IBM built their first computer in 1953. And they still operate that way. We were born into a world that conquers complex problems with state-of-the-art, AI-driven technology. Our catalog is one of the largest, smartest public medical supply catalog in the world, with over 500,000 products and growing. We solve complex pricing, contracting, and sourcing problems — automatically.
The Medical Supply Industry Is Broken
iRemedy has assembled the best of the best for a winning team. From Microsoft to Amazon, to multiple successful exits, the iRemedy team we feel are positioned to continue to grow this multi-million dollar company into a medical supply giant.
Smart. Transparent. Revolutionary.
Patients and healthcare providers deserve the peace of mind that comes from knowing they have what they need, when they need it most. They deserve to reach their health goals. They deserve to offer patients the best care possible. That’s where iRemedy comes in.
90% of All Medical Supplies are Sourced in Asia
iRemedy’s mission is to focus on more domestic supply and a more resilient global supply chain.
Health and medical supplies delivered fast, when you need them most.
Join the movement in the AI-powered medical marketplace disrupting the $130 billion medical supply market.
The Time For Change is Now.
There’s never been a better time to empower patients and healthcare providers with a service that will not only make their lives easier but will literally save lives. When you invest in iRemedy, you’re investing in the future of healthcare — an industry desperate for revolutionary modernization. Be a part of this incredible technology-fueled step forward. Join our growing community of investors today.
Revolutionize the Broken and Corrupt Medical Industry With Us
Having access to medical supplies can be an issue of life or death. Waiting is not an option, and going through red tape only makes helping people harder. The medical supply industry is failing patients. iRemedy has a disruptive solution to transform the industry. Our catalog is one of the largest, smartest public medical supply catalog in the world, with over 500,000 products and growing. We solve complex pricing, contracting, and sourcing problems — automatically. The gold standard is here, and it’s going to change everything.
Executive Leadership Team
iRemedy has assembled the best of the best for a winning team. From Microsoft to Amazon, to multiple successful exits, the iRemedy team is positioned to continue to grow this multi-million dollar company into a medical supply giant.
- Founder and CEO, Agency One / AMS; Sold to CNA Insurance
- Founder and CEO, Medinex; IPO on Nasdaq
- Ten-year advisor to C-Suite healthcare leaders
- Twelve patents filed, three issued
- Author of two healthcare books
- One of the creators of PC-DOS, licensed to Microsoft
- VP Technology, Amazon; built and launched the Amazon Marketplace
- Sold two companies to Amazon (Cartia, PhotoTrust)
- Sixteen patents filed, six issued
iRemedy Current Revenue
Our Physician and Healthcare Professional Investors
JOIN TODAY AND MAKE A CHANGE
Invest in iRemedy
iRemedy will soon change forever the way medical supplies are sourced in the United States. Confusing prices, product shortages, and outrageous costs will be a thing of the past as we modernize the supply chain with artificial intelligence. Now is the time.
STUART, FL – (GLOBE NEWSWIRE) – June 26, 2023 – The iRemedy Healthcare Companies, Inc....
Companies to Launch Integrated Supply Purchasing and Service Platform for Urgent Care CentersSTUART, FLORIDA, U.S,...
Podcast iRemedy Debuts “The Supply Side“ Podcast, Unveiling Insights into the Medical Supply Chain and Healthcare IndustrySTUART, FL – June 15, 2023 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the...
We believe there are two great reasons to invest in iRemedy Healthcare. First, healthcare costs in America are among the highest in the world and a major factor in that cost is the non-competitive nature of medical supply sales. Investing in iRemedy Healthcare is a way to participate in a new model of lower medical supply costs and subsequently, lower healthcare costs in America. Secondly, the medical supply industry is one of the largest vertical markets in the country with sales exceeding $100B. The timing is excellent to utilize a new AI marketplace platform to achieve continued rapid sales growth.
As a healthcare professional you will be able to be an owner and participant in the company from which you purchase your medical supplies. Also, owners in iRemedy Healthcare qualify for a discount on their medical supply purchasing as well as free shipping.
The founders and senior executives of iRemedy Healthcare have had multiple successful exits including acquisitions and a NASDAQ public offering. The executive team is committed to an expeditious successful exit, either via acquisition or IPO.
Our offering is open to US and international investors.
You can view our offering circular at the link below. We recommend you read it before investing:
<Insert link to circular offering>
Contact iRemedy Healthcare directly for a phone consultation or further information.
<Insert contact link>
Let us know if you have any additional questions.
iRemedy Healthcare has a proprietary AI driven marketplace protected by patents issued and patents filed/pending. There are many ‘legacy’ vendors in medical supply distribution but none that are manufacturer, distributor, vendor, and product agnostic.
Proceeds from this offering will be used to further develop iRemedy’s AI Marketplace technology and expand the company’s sales and marketing teams.
iRemedy Healthcare plans on expanding our medical supply distribution business to encompass worldwide sourcing and distribution of products largely due to our proprietary AI marketplace platform.